Try our Advanced Search for more refined results

July 07, 2021

United States Securities and Exchange Commission v. Parallax Health Sciences, Inc. et al

Track this case

Case Number:

1:21-cv-05812

Court:

New York Southern

Nature of Suit:

Securities/Commodities

Government Agencies

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. July 07, 2021

    SEC Says Health Care Co. Lied About COVID-19 Readiness

    A health care company has been accused in New York federal court by the U.S. Securities and Exchange Commission of leading stakeholders astray by issuing allegedly misleading proclamations about COVID-19 screening tests and related medical equipment.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login